Terms: = Sarcomas AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Treatment
16 results:
1. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract] [Full Text] [Related]
2. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract] [Full Text] [Related]
3. [Segmental vena cava resection for the treatment of renal tumor with invading tumor thrombus].
Ye JF; Ma LL; Zhao L; Wang GL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):183-187. PubMed ID: 29483744
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.
Hwang IK; Hahn SM; Kim HS; Kim SK; Kim HS; Shin KH; Suh CO; Lyu CJ; Han JW
Cancer Res Treat; 2017 Jul; 49(3):717-726. PubMed ID: 28052660
[TBL] [Abstract] [Full Text] [Related]
5. High-grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging.
Lou S; Balluff B; de Graaff MA; Cleven AH; Briaire-de Bruijn I; Bovée JV; McDonnell LA
Proteomics; 2016 Jun; 16(11-12):1802-13. PubMed ID: 27174013
[TBL] [Abstract] [Full Text] [Related]
6. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee.
Bishop MW; Chang YC; Krailo MD; Meyers PA; Provisor AJ; Schwartz CL; Marina NM; Teot LA; Gebhardt MC; Gorlick R; Janeway KA; Chou AJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1737-43. PubMed ID: 27128693
[TBL] [Abstract] [Full Text] [Related]
7. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital.
Nanteza M; Tusiime JB; Kalyango J; Kasangaki A
BMC Oral Health; 2014 Nov; 14():143. PubMed ID: 25432363
[TBL] [Abstract] [Full Text] [Related]
8. Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.
Lindberg JM; Newhook TE; Adair SJ; Walters DM; Kim AJ; Stelow EB; Parsons JT; Bauer TW
Neoplasia; 2014 Jul; 16(7):562-71. PubMed ID: 25117978
[TBL] [Abstract] [Full Text] [Related]
9. Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.
Gantt S; Cattamanchi A; Krantz E; Magaret A; Selke S; Kuntz SR; Huang ML; Corey L; Wald A; Casper C
J Clin Virol; 2014 Jun; 60(2):127-32. PubMed ID: 24698158
[TBL] [Abstract] [Full Text] [Related]
10. Surgery alone is adequate treatment for early stage soft tissue sarcoma of the extremity.
Al-Refaie WB; Habermann EB; Jensen EH; Tuttle TM; Pisters PW; Virnig BA
Br J Surg; 2010 May; 97(5):707-13. PubMed ID: 20235085
[TBL] [Abstract] [Full Text] [Related]
11. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients.
Campana LG; Mocellin S; Basso M; Puccetti O; De Salvo GL; Chiarion-Sileni V; Vecchiato A; Corti L; Rossi CR; Nitti D
Ann Surg Oncol; 2009 Jan; 16(1):191-9. PubMed ID: 18987914
[TBL] [Abstract] [Full Text] [Related]
12. Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans.
Adler N; Tsabari C; Sulkes J; Ad-El D; Feinmesser M
J Cutan Pathol; 2008 Jun; 35(6):532-5. PubMed ID: 18201240
[TBL] [Abstract] [Full Text] [Related]
13. Cytotoxicity of treosulfan and busulfan on pediatric tumor cell lines.
Lanvers-Kaminsky C; Bremer A; Dirksen U; Jürgens H; Boos J
Anticancer Drugs; 2006 Jul; 17(6):657-62. PubMed ID: 16917211
[TBL] [Abstract] [Full Text] [Related]
14. [G-CSF and GM-CSF in treatment of neutropaenia after chemotherapy in children with neoplasms].
Chybicka A; Bogusławska-Jaworska J; Rosińska B; Wecławek-Tompol J; Armata J; Balcerska A; Balwierz W; Bubala H; Drabko K; Eliasinska A; Kedziora M; Sońta-Jakimczyk D; Sopylo B; Kołecki P; Kowalczyk J; Matysiak M; Rokicka-Milewska R; Stefaniak MJ; Stańczak E; Stencel D; Wysocki M; Płoszyńska A
Med Wieku Rozwoj; 2000; 4(1 Suppl 2):121-9. PubMed ID: 12021471
[TBL] [Abstract] [Full Text] [Related]
15. Expression and characterization of recombinant human protein S in heterologous cells--studies of the interaction of amino acid residues leu-608 to glu-612 with human C4b-binding protein.
Chang GT; Ploos van Amstel HK; Hessing M; Reitsma PH; Bertina RM; Bouma BN
Thromb Haemost; 1992 May; 67(5):526-32. PubMed ID: 1325680
[TBL] [Abstract] [Full Text] [Related]
16. Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas.
Peacock JL; Inculet RI; Corsey R; Ford DB; Rumble WF; Lawson D; Norton JA
Surgery; 1987 Sep; 102(3):465-72. PubMed ID: 3629474
[TBL] [Abstract] [Full Text] [Related]
